Collins, Steven

Quantifying prion disease penetrance using large population control cohorts

Minikel, E. V., Vallabh, S. M., Lek, M., Estrada, K., Samocha, K. E., Sathirapongsasuti, J. F., McLean, C. Y., Tung, J. Y., Yu, L. P. C., Gambetti, P., et al. (2016) · Science Translational Medicine

Prion Diseases and Protein MisfoldingGenomics and Rare Diseases

Cited by 442

Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture

Zhang, Q., Sidorenko, J., Couvy-Duchesne, B., Marioni, R. E., Wright, M. J., Goate, A. M., Marcora, E., Huang, K.-L., Porter, T., Laws, S. M., et al. (2020) · Nature Communications

Alzheimer's disease research and treatmentsGenetic Associations and Epidemiology

Cited by 272

Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer’s Disease

Fowler, C., Rainey-Smith, S. R., Bird, S., Bomke, J., Bourgeat, P., Brown, B. M., Burnham, S. C., Bush, A. I., Chadunow, C., Collins, S., et al. (2021) · Journal of Alzheimer's Disease Reports

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 164

Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease

Dhiman, K., Gupta, V. B., Villemagne, V. L., Eratne, D., Graham, P. L., Fowler, C., Bourgeat, P., Li, Q., Collins, S., Bush, A. I., et al. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 93

A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: a ‘C-reactive protein’ for psychiatrists and neurologists?

Eratne, D., Loi, S. M., Walia, N., Farrand, S., Li, Q.-X., Varghese, S., Walterfang, M., Evans, A., Mocellin, R., Dhiman, K., et al. (2020) · Australian & New Zealand Journal of Psychiatry

Dementia and Cognitive Impairment ResearchCerebrospinal fluid and hydrocephalus

Cited by 56

GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells

Si, J., Mueller, L., & Collins, S. J. (2011) · Leukemia

Retinoids in leukemia and cellular processesWnt/β-catenin signaling in development and cancer

Cited by 30

Cerebrospinal fluid neurofilament light chain is elevated in Niemann–Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment response

Eratne, D., Loi, S. M., Li, Q.-X., Varghese, S., McGlade, A., Collins, S., Masters, C. L., Velakoulis, D., & Walterfang, M. (2020) · Australian & New Zealand Journal of Psychiatry

Lysosomal Storage Disorders ResearchGenetic Neurodegenerative Diseases

Cited by 30

Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer’s disease

Lim, B., Fowler, C., Li, Q.-X., Rowe, C., Dhiman, K., Gupta, V. B., Masters, C. L., Doecke, J. D., Martins, R. N., Collins, S., et al. (2020) · Neuroscience Letters

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 10

Cerebrospinal fluid neurofilament light and cerebral atrophy in younger‐onset dementia and primary psychiatric disorders

Walia, N., Eratne, D., Loi, S. M., Farrand, S., Li, Q., Malpas, C. B., Varghese, S., Walterfang, M., Evans, A. H., Parker, S., et al. (2023) · Internal Medicine Journal

Dementia and Cognitive Impairment ResearchCerebrospinal fluid and hydrocephalus

Cited by 6